Back
Lixte Biotechnology Holdings Vs. Syros Pharmaceuticals Industry Stock Comparison
Sell
28
LIXT
Lixte Biotechnology Holdings
Last Price:
2.48
Seasonality Move:
26.57%
Buy
86
SYRS
Syros Pharmaceuticals
Last Price:
5.44
Seasonality Move:
17.51%
Sell
28
Lixte Biotechnology Holdings (LIXT)
is a Sell
Is Lixte Biotechnology Holdings a Buy, Sell or Hold?
- The current Lixte Biotechnology Holdings [LIXT] share price is $2.38. The Score for LIXT is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- LIXT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
86
Syros Pharmaceuticals (SYRS)
is a Buy
Is Syros Pharmaceuticals a Buy, Sell or Hold?
- The current Syros Pharmaceuticals [SYRS] share price is $5.48. The Score for SYRS is 86, which is 72% above its historic median score of 50, and infers lower risk than normal.
- SYRS is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
LIXT Stock Price Chart
What is Lixte Biotechnology Holdings's stock price today?
-
The Lixte Biotechnology Holdings share price today is $2.38
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LIXT is experiencing slight selling pressure.
SYRS Stock Price Chart
What is Syros Pharmaceuticals's stock price today?
-
The Syros Pharmaceuticals share price today is $5.48
The current trend is relatively stagnant and SYRS is experiencing slight buying pressure.
LIXT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.17 | Sell |
| Relative Strength Index (14 RSI): | 35.53 | Sell |
| Chaikin Money Flow: | -5540 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.65 - 3.35) | Sell |
| Bollinger Bands (100): | (2.09 - 3.09) | Sell |
SYRS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 54.58 | Buy |
| Chaikin Money Flow: | 743 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.93 - 5.41) | Buy |
| Bollinger Bands (100): | (5.37 - 7.29) | Sell |
LIXT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.6 | Sell |
| 20-day SMA: | 2.91 | Sell |
| 50-day SMA: | 2.91 | Sell |
| 200-day SMA: | 2.53 | Sell |
| 8-day EMA: | 2.58 | Sell |
| 20-day EMA: | 2.8 | Sell |
| 50-day EMA: | 2.84 | Sell |
| 200-day EMA: | 3.21 | Sell |
SYRS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.2 | Buy |
| 20-day SMA: | 5.16 | Buy |
| 50-day SMA: | 5.5 | Sell |
| 200-day SMA: | 4.88 | Buy |
| 8-day EMA: | 5.29 | Buy |
| 20-day EMA: | 5.25 | Buy |
| 50-day EMA: | 5.51 | Sell |
| 200-day EMA: | 5.34 | Buy |
Lixte Biotechnology Holdings Earnings Growth & LIXT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Syros Pharmaceuticals Earnings Growth & SYRS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.08 per share, an increase this year of $0.95 per share, and a decrease next year of $0.49 per share.
Lixte Biotechnology Holdings Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Syros Pharmaceuticals Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||